Pyrazinamide News and Research

RSS
TB Alliance initiates SimpliciTB to test if new four-drug regimen can treat most types of tuberculosis

TB Alliance initiates SimpliciTB to test if new four-drug regimen can treat most types of tuberculosis

Higher doses of rifampin kill more TB bacteria in sputum without increasing adverse effects

Higher doses of rifampin kill more TB bacteria in sputum without increasing adverse effects

Researchers tackling deadly TB discuss the way forward in treatment and prevention

Researchers tackling deadly TB discuss the way forward in treatment and prevention

UCLA-led researchers identify potential TB drug regimen that may cut treatment time up to 75%

UCLA-led researchers identify potential TB drug regimen that may cut treatment time up to 75%

Cochrane review explores FDCs versus single-drug formulations for treatment of pulmonary TB

Cochrane review explores FDCs versus single-drug formulations for treatment of pulmonary TB

Clinical study finds no added benefit of using four TB drugs to save people with advanced HIV/AIDS

Clinical study finds no added benefit of using four TB drugs to save people with advanced HIV/AIDS

Treating multidrug-resistant tuberculosis with regimens may improve outcomes

Treating multidrug-resistant tuberculosis with regimens may improve outcomes

TB Alliance receives Australian DFAT grant to support late-stage clinical trials of new TB drugs

TB Alliance receives Australian DFAT grant to support late-stage clinical trials of new TB drugs

PaMZ drug regimen shows potential to improve treatment for MDR-TB

PaMZ drug regimen shows potential to improve treatment for MDR-TB

Eating food just before taking TB drug could reduce effectiveness of medicine

Eating food just before taking TB drug could reduce effectiveness of medicine

Researchers discover new clue to understanding how TB medication attacks dormant TB bacteria

Researchers discover new clue to understanding how TB medication attacks dormant TB bacteria

TB Alliance advances first-ever TB drug regimen to global Phase 3 clinical trial

TB Alliance advances first-ever TB drug regimen to global Phase 3 clinical trial

EPFL sets up foundation to release antibiotic for tuberculosis

EPFL sets up foundation to release antibiotic for tuberculosis

TB Alliance, Svizera Europe partner to create, enable access to new medicines for childhood TB

TB Alliance, Svizera Europe partner to create, enable access to new medicines for childhood TB

BP and headache drug effectively speeds up treatment of TB

BP and headache drug effectively speeds up treatment of TB

Study provides new insight into how pyrazinamide works

Study provides new insight into how pyrazinamide works

Clinical trial to examine AstraZeneca experimental drug against pulmonary tuberculosis

Clinical trial to examine AstraZeneca experimental drug against pulmonary tuberculosis

TB Alliance and FIND partner to promote development of TB drugs and diagnostics

TB Alliance and FIND partner to promote development of TB drugs and diagnostics

TB combination drug: an interview with Mel Spigelman, MD, CEO and President of TB Alliance

TB combination drug: an interview with Mel Spigelman, MD, CEO and President of TB Alliance

New combination therapy for TB shows promise in Phase II study

New combination therapy for TB shows promise in Phase II study